Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON—AdvaMed, the Medtech Association, is pleased to announce Charles Fleischman as the first-ever recipient of the AdvaMedDx Lifetime of Leadership & Service Award.
WASHINGTON—AdvaMed, the medtech association, today thanked the U.S. House Energy and Commerce Health Subcommittee for highlighting the need for Medicare coverage of FDA-authorized breakthrough medtech and releasing a discussion draft…
WASHINGTON—AdvaMed, the medtech association, today welcomed U.S. House of Representatives Committee on Ways and Means passage of legislation providing Medicare coverage of FDA-designated and authorized breakthrough medtech. AdvaMed also urged…
WASHINGTON—AdvaMed, the medtech association, welcomed today’s CMS’ announcement of the details of the $50 billion Rural Health Transformation Program. This program gives states the chance to access the latest health…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
WASHINGTON—AdvaMed, the medtech association, today welcomed the introduction in the U.S. House of Representatives and Senate of the bipartisan Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act…
WASHINGTON, D.C.—AdvaMed, the Medtech Association, is among 67 stakeholder groups, including patient advocacy groups and state medtech and life sciences associations, urging the Centers for Medicare and Medicaid Services (CMS)…
WASHINGTON, D.C.—AdvaMed, the medtech association, today welcomed the kickoff of the latest Medical Device User Fee Amendments (MDUFA) discussion at a public meeting at FDA headquarters. Three AdvaMed senior staff…
WASHINGTON, D.C. – In a new op-ed in The Washington Times, Scott Whitaker, president and CEO of AdvaMed, the Medtech Association, laid out medtech’s vital role in the Trump administration’s…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the medtech association, issued the following statement on the White House’s “America’s AI Action Plan”: